1. Home
  2. GCTK

as of 01-05-2026 11:06am EST

$3.85
$0.00
0.00%
Stocks Health Care Medical/Dental Instruments Nasdaq

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Founded: 2001 Country:
United States
United States
Employees: N/A City: RUTHERFORD
Market Cap: 4.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 72.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -65.45 EPS Growth: N/A
52 Week Low/High: $3.21 - $468.00 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered GCTK Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 84.72%
84.72%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest GlucoTrack Inc. News

GCTK Breaking Stock News: Dive into GCTK Ticker-Specific Updates for Smart Investing

All GCTK News

Share on Social Networks: